ERG and CHDI Heterogeneity in Prostate Cancer: Use of Confocal Microscopy in Assessment of Microscopic Foci

作者：Tereshchenko Irina V; Zhong Hua; Chekmareva Marina A; Kane Goldsmith Noriko; Santanam Urmila; Petrosky Whitney; Stein Mark N; Ganesan Shridar; Singer Eric A; Moore Dirk; Tischfield Jay A; DiPaola Robert S^*

来源：Prostate, 2014, 74(15): 1551-1559.

DOI：10.1002/pros.22873

• prostate cancer
• ERG
• TMPRSS2
• heterogeneity
• confocal microscopy
• CHD1

BACKGROUND. Biomarkers predicting tumor response are important to emerging targeted therapeutics. Complimentary methods to assess and understand genetic changes and heterogeneity within only few cancer cells in tissue will be a valuable addition for assessment of tumors such as prostate cancer that often have insufficient tumor for next generation sequencing in a single biopsy core.
METHODS. Using confocal microscopy to identify cell-to-cell relationships in situ, we studied the most common gene rearrangement in prostate cancer (TMPRSS2 and ERG) and the tumor suppressor CHD1 in 56 patients who underwent radical prostatectomy.
RESULTS. Wild type ERG was found in 22 of 56 patients; ERG copy number was increased in 10/56, and ERG rearrangements confirmed in 24/56 patients. In 24 patients with ERG rearrangements, the mechanisms of rearrangement were heterogeneous, with deletion in 14/24, a split event in 7/24, and both deletions and split events in the same tumor focus in 3/24 patients. Overall, 14/45 (31.1%) of patients had CHD1 deletion, with the majority of patients with CHD1 deletions (13/14) correlating with ERG-rearrangement negative status (P < 0.001).
CONCLUSIONS. These results demonstrate the ability of confocal microscopy and FISH to identify the cell-to-cell differences in common gene fusions such as TMPRSS2 ERG that may arise independently within the same tumor focus. These data support the need to study complimentary approaches to assess genetic changes that may stratify therapy based on predicted sensitivities.

• 出版日期2014-11
• 单位rutgers